Resolution of granuloma faciale with topical tacrolimus. 2020

Francisco S Gil, and Joana Parente, and João Aranha
Dermatology Department, Hospital de Santarém EPE, Santarém, Portugal.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008297 Male Males
D005148 Facial Dermatoses Skin diseases involving the FACE. Favre-Racouchot Syndrome,Nodular Elastoidosis,Facial Dermatosis,Nodular Elastosis,Dermatoses, Facial,Dermatosis, Facial,Elastoidoses, Nodular,Elastoidosis, Nodular,Elastoses, Nodular,Elastosis, Nodular,Favre Racouchot Syndrome,Nodular Elastoidoses,Nodular Elastoses,Syndrome, Favre-Racouchot
D006099 Granuloma A relatively small nodular inflammatory lesion containing grouped mononuclear phagocytes, caused by infectious and noninfectious agents. Granulomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000287 Administration, Topical The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example. Drug Administration, Topical,Administration, Topical Drug,Topical Administration,Topical Drug Administration,Administrations, Topical,Administrations, Topical Drug,Drug Administrations, Topical,Topical Administrations,Topical Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D016559 Tacrolimus A macrolide isolated from the culture broth of a strain of Streptomyces tsukubaensis that has strong immunosuppressive activity in vivo and prevents the activation of T-lymphocytes in response to antigenic or mitogenic stimulation in vitro. Anhydrous Tacrolimus,FK-506,FK506,FR-900506,Prograf,Prograft,Tacrolimus Anhydrous,Anhydrous, Tacrolimus,FK 506,FR 900506,FR900506,Tacrolimus, Anhydrous

Related Publications

Francisco S Gil, and Joana Parente, and João Aranha
November 2006, Journal of the American Academy of Dermatology,
Francisco S Gil, and Joana Parente, and João Aranha
April 2009, Clinical and experimental dermatology,
Francisco S Gil, and Joana Parente, and João Aranha
August 2009, The Australasian journal of dermatology,
Francisco S Gil, and Joana Parente, and João Aranha
December 2010, International journal of dermatology,
Francisco S Gil, and Joana Parente, and João Aranha
March 2008, Acta dermatovenerologica Alpina, Pannonica, et Adriatica,
Francisco S Gil, and Joana Parente, and João Aranha
July 2016, Dermatology online journal,
Francisco S Gil, and Joana Parente, and João Aranha
January 2015, Anais brasileiros de dermatologia,
Francisco S Gil, and Joana Parente, and João Aranha
October 2004, Dermatology online journal,
Francisco S Gil, and Joana Parente, and João Aranha
May 2012, Case reports in dermatology,
Francisco S Gil, and Joana Parente, and João Aranha
January 2014, Acta dermatovenerologica Croatica : ADC,
Copied contents to your clipboard!